Search Results - "Dockter, J"

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial by Advani, Pooja P, Ballman, Karla V, Dockter, Travis J, Colon-Otero, Gerardo, Perez, Edith A

“…Significant improvement in survival outcomes has been established with the addition of trastuzumab to adjuvant chemotherapy for human epidermal growth factor…”
Get full text

Quality control and assessment of interpreter consistency of annual land cover reference data in an operational national monitoring program by Pengra, Bruce W., Stehman, Stephen V., Horton, Josephine A., Dockter, Daryn J., Schroeder, Todd A., Yang, Zhiqiang, Cohen, Warren B., Healey, Sean P., Loveland, Thomas R.

“…The U.S. Geological Survey Land Change Monitoring, Assessment and Projection (USGS LCMAP) initiative is working toward a comprehensive capability to…”
Get full text

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study by Bekaii-Saab, Tanios S, Prof, Ou, Fang-Shu, PhD, Ahn, Daniel H, DO, Boland, Patrick M, MD, Ciombor, Kristen K, MD, Heying, Erica N, BS, Dockter, Travis J, MS, Jacobs, Nisha L, MD, Pasche, Boris C, Prof, Cleary, James M, MD, Meyers, Jeffrey P, BS, Desnoyers, Rodwige J, MD, McCune, Jeannine S, Prof, Pedersen, Katrina, MD, Barzi, Afsaneh, MD, Chiorean, E Gabriela, Prof, Sloan, Jeffrey, Prof, Lacouture, Mario E, Prof, Lenz, Heinz-Josef, Prof, Grothey, Axel, MD

“…SummaryBackgroundRegorafenib confers an overall survival benefit in patients with refractory metastatic colorectal cancer; however, the adverse event profile…”
Get full text

Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial by Serie, Daniel J, Crook, Julia E, Necela, Brian M, Dockter, Travis J, Wang, Xue, Asmann, Yan W, Fairweather, DeLisa, Bruno, Katelyn A, Colon-Otero, Gerardo, Perez, Edith A, Thompson, E Aubrey, Norton, Nadine

“…The major clinical side effect of the ERBB2-targeted breast cancer therapy, trastuzumab, is a decline in the left ventricular ejection fraction (LVEF)…”
Get full text

North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study by Leal, Alexis D., Qin, Rui, Atherton, Pamela J., Haluska, Paul, Behrens, Robert J., Tiber, Charles H., Watanaboonyakhet, Patanit, Weiss, Matthias, Adams, Paul T., Dockter, Travis J., Loprinzi, Charles L.

“…BACKGROUND Chemotherapy‐induced peripheral neuropathy (CIPN) is a significant side effect of taxane and platinum‐based chemotherapy. Several studies have…”
Get full text

Perspectives of physicians and nurses on identifying and treating psychological distress of the critically ill by Karnatovskaia, Lioudmila V., MD, Johnson, Margaret M., MD, Dockter, Travis J., MS, Gajic, Ognjen, MD

“…Abstract Purpose Survivors of critical illness are frequently unable to return to their pre-morbid level of psychocognitive functioning following discharge…”
Get full text

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer by Goetz, Matthew P, Kalari, Krishna R, Suman, Vera J, Moyer, Ann M, Yu, Jia, Visscher, Daniel W, Dockter, Travis J, Vedell, Peter T, Sinnwell, Jason P, Tang, Xiaojia, Thompson, Kevin J, McLaughlin, Sarah A, Moreno-Aspitia, Alvaro, Copland, John A, Northfelt, Donald W, Gray, Richard J, Hunt, Katie, Conners, Amy, Sicotte, Hugues, Eckel-Passow, Jeanette E, Kocher, Jean-Pierre, Ingle, James N, Ellingson, Marissa S, McDonough, Michelle, Wieben, Eric D, Weinshilboum, Richard, Wang, Liewei, Boughey, Judy C

“…Breast cancer patients with residual disease after neoadjuvant chemotherapy (NAC) have increased recurrence risk. Molecular characterization, knowledge of NAC…”
Get full text

Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA by GIACHETTI, C, LINNEN, J. M, KOLK, D. P, DOCKTER, J, GILLOTTE-TAYLOR, K, PARK, M, HO-SING-LOY, M, MCCORMICK, M. K, MIMMS, L. T, MCDONOUGH, S. H

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy by Mosley, J. W., Operskalski, E. A., Tobler, L. H., Buskell, Z. J., Andrews, W. W., Phelps, B., Dockter, J., Giachetti, C., Seeff, L. B., Busch, M. P.

“…Knowing the likely distribution of intervals from hepatitis C infection to first RNA‐negativity is important in deciding about therapeutic intervention…”
Get full text

Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy by Serie, Daniel J, Crook, Julia E, Necela, Brian M, Axenfeld, Bianca C, Dockter, Travis J, Colon-Otero, Gerardo, Perez, Edith A, Thompson, E Aubrey, Norton, Nadine

“…Doxorubicin and the ERBB2 targeted therapy, trastuzumab, are routinely used in the treatment of HER2+ breast cancer. In mouse models, doxorubicin is known to…”
Get full text

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge by von Herrath, M G, Yokoyama, M, Dockter, J, Oldstone, M B, Whitton, J L

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Detection of HIV-1 in alternative specimen types using the APTIMA ® HIV-1 RNA Qualitative Assay by Nugent, C. Thomas, Dockter, J., Bernardin, F., Hecht, R., Smith, D., Delwart, E., Pilcher, C., Richman, D., Busch, M., Giachetti, C.

“…Peripheral blood mononuclear cells (PBMCs), saliva, seminal plasma, and dried blood spots were evaluated as specimen types for the APTIMA HIV-1 RNA Qualitative…”
Get full text

Music Therapy Intervention to Reduce Caregiver Distress at End of Life: A Feasibility Study by Whitford, Kevin J., Ulrich, Angela M., Larsen, Brianna E., Phelps, Christina M., Siska, Martha J., Bigelow, Maureen L., Dockter, Travis J., Wood, Christina, Walton, Monica P., Stelpflug, Amy J., Lapid, Maria I.

“…Music therapy (MT) can relieve distressing end-of-life symptoms, but little is known regarding its effect on caregivers who are at risk for emotional distress…”
Get full text

Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912) by Hertz, Daniel L., Dockter, Travis J., Satele, Daniel V., Loprinzi, Charles L., Le-Rademacher, Jennifer

“…Background Clinical guidelines recommend altering chemotherapy treatment by decreasing, delaying, or discontinuing dosing in patients who are experiencing…”
Get full text

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) by Freedman, Rachel A., Dockter, Travis J., Lafky, Jacqueline M., Hurria, Arti, Muss, Hyman J., Cohen, Harvey J., Jatoi, Aminah, Kemeny, M. Margaret, Ruddy, Kathryn J.

“…Background There are multiple known individual‐ and practice‐level barriers to enrollment of older patients with cancer to clinical trials, but little is known…”
Get full text

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA by McCormick, M.K., Dockter, J., Linnen, J.M., Kolk, D., Wu, Y., Giachetti, C.

“…Rapid, sensitive, specific, and cost-effective screening of donated blood to prevent transmission of infectious agents remains challenging. In recent years,…”
Get full text

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance) by Blum, Kristie A., Polley, Mei‐Yin, Jung, Sin‐Ho, Dockter, Travis J., Anderson, Sarah, Hsi, Eric D., Wagner‐Johnston, Nina, Christian, Beth, Atkins, Jim, Cheson, Bruce D., Leonard, John P., Bartlett, Nancy L.

“…Background This multicenter, randomized phase 2 trial evaluated complete responses (CRs), efficacy, and safety with ofatumumab and bendamustine and with…”
Get full text

Dorsoventral axis determination in the somite: a re-examination by Dockter, J, Ordahl, C P

“…We have repeated classic dorsoventral somite rotation experiments (Aoyama and Asamoto, 1988, Development 104, 15–28) and included dorsal and ventral gene…”
Get full text

Music Therapy Intervention to Reduce Symptom Burden in Hospice Patients: A Descriptive Study by Estell, Madison H., Whitford, Kevin J., Ulrich, Angela M., Larsen, Brianna E., Wood, Christina, Bigelow, Maureen L., Dockter, Travis J., Schoonover, Kimberly L., Stelpflug, Amy J., Strand, Jacob J., Walton, Monica P., Lapid, Maria I.

“…Background: Music therapy (MT) offers benefits of improved symptom relief and quality of life at the end of life, but its impact on hospice patients and…”
Get full text

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall by Moyer, Ann M, Yu, Jia, Sinnwell, Jason P, Dockter, Travis J, Suman, Vera J, Weinshilboum, Richard M, Boughey, Judy C, Goetz, Matthew P, Visscher, Daniel W, Wang, Liewei

“…Patient-derived xenografts (PDX) are generated in immune deficient mice and demonstrate histologic and molecular features similar to their corresponding human…”
Get full text